Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serota

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Open Forum Infectious Diseases|January 12, 2023
Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use-Associated Infections: A Prospective Cohort Study With Historical ControlDavid P Serota, Liza Rosenbloom, Belén Hervera, et al.
Drug and Alcohol Dependence|November 15, 2021
Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugsHansel E Tookes, Tyler S Bartholomew, Edward Suarez, et al.
The Journal of Nutrition|March 5, 2023
Vitamin D and SARS-CoV-2 Infection: SERVE Study (SARS-CoV-2 Exposure and the Role of Vitamin D among Hospital Employees)Yi Liu, Shannon Clare, Gia D'Erasmo, et al.
Addiction Science & Clinical Practice|November 19, 2022
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper surveyAlina Syros, Maria G Rodriguez, Andrew C Rennick, et al.
Addiction Science & Clinical Practice|March 26, 2024
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention servicesTyler S Bartholomew, Marina Plesons, David P Serota, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2015
Tropical nighttime warming as a dominant driver of variability in the terrestrial carbon sinkWilliam R L Anderegg, Ashley P Ballantyne, W Kolby Smith, et al.
Trials|February 8, 2023
Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugsHansel E Tookes, Asa Oxner, David P Serota, et al.
Addiction Science & Clinical Practice|February 21, 2026
Integrated infectious disease and substance use disorder treatment for severe injection-related infections: protocol for the randomized controlled HI-SIRI trialDavid P Serota, Daniel J Feaster, Tyler S Bartholomew, et al.
Frontiers in Cardiovascular Medicine|May 29, 2024
Arrhythmia monitoring and outcome after myocardial infarction (BIO|GUARD-MI): a randomized trialChristian Jøns, Poul Erik Bloch Thomsen, Sam Riahi, et al.
Open Forum Infectious Diseases|September 22, 2020
Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019Stephen R Morris, Yoichiro Natori, Douglas Salguero, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Open Forum Infectious Diseases|January 12, 2023
Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use-Associated Infections: A Prospective Cohort Study With Historical ControlDavid P Serota, Liza Rosenbloom, Belén Hervera, et al.
Drug and Alcohol Dependence|November 15, 2021
Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugsHansel E Tookes, Tyler S Bartholomew, Edward Suarez, et al.
The Journal of Nutrition|March 5, 2023
Vitamin D and SARS-CoV-2 Infection: SERVE Study (SARS-CoV-2 Exposure and the Role of Vitamin D among Hospital Employees)Yi Liu, Shannon Clare, Gia D'Erasmo, et al.
Addiction Science & Clinical Practice|November 19, 2022
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper surveyAlina Syros, Maria G Rodriguez, Andrew C Rennick, et al.
Addiction Science & Clinical Practice|March 26, 2024
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention servicesTyler S Bartholomew, Marina Plesons, David P Serota, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2015
Tropical nighttime warming as a dominant driver of variability in the terrestrial carbon sinkWilliam R L Anderegg, Ashley P Ballantyne, W Kolby Smith, et al.
Trials|February 8, 2023
Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugsHansel E Tookes, Asa Oxner, David P Serota, et al.
Addiction Science & Clinical Practice|February 21, 2026
Integrated infectious disease and substance use disorder treatment for severe injection-related infections: protocol for the randomized controlled HI-SIRI trialDavid P Serota, Daniel J Feaster, Tyler S Bartholomew, et al.
Frontiers in Cardiovascular Medicine|May 29, 2024
Arrhythmia monitoring and outcome after myocardial infarction (BIO|GUARD-MI): a randomized trialChristian Jøns, Poul Erik Bloch Thomsen, Sam Riahi, et al.
Open Forum Infectious Diseases|September 22, 2020
Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019Stephen R Morris, Yoichiro Natori, Douglas Salguero, et al.
Pageof 27